Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.



Published on


  1. 1. MycobacteriumSaddam AnsariTbilisi State Medical University
  2. 2. Kingdom: BacteriaPhylum: ActinobacteriaOrder: ActinomycetalesSuborder: CorynebacterineaeFamily: MycobacteriaceaeGenus: Mycobacterium
  3. 3.  Mycobacterium Tuberculosis Mycobacterium Leprae(uncommon)
  4. 4. Lipid Rich Cell WallMycolic acids
  5. 5. Acid-Fast (Kinyoun) Stain Cord growth(Serpentinearrangement) ofvirulent strains. Kinyoun similarto Ziehl-NeelsenStain
  6. 6. Ziehl-Neelsen StainProcedure 1. Cover with tissue paper or if notthen without paper its possible. 2. Flood slide with carbolfuchsin, theprimary stain, for 3-5 minutes whileheating with steam or heating on hotplate.
  7. 7. Continued… 3. Remove paper cover, decolorizeslide with a mixture of hydrochloricacid and ethanol. 4. Counterstain with methylene blue orMalachite green.
  8. 8. Pathogenic MycobacteriumM. tuberculosis Complex◦ M. tuberculosis - Common◦ M. leprae - Uncommon◦ M. africanum◦ M. bovis Rare◦ M. ulceransAll are Strictly Pathogenic
  9. 9. Continued…Runyon Group I (Slow growingphotochromogens)◦ M. kanasii - Common◦ M. marinum◦ M. simae UncommonAll are usually pathogenic not strictly
  10. 10. Continued…Runyon Group II (Slow growingscotochromogens)◦ M. szulgai◦ M. scrofulaceum Uncommon◦ M. xenopiUsually pathogenicSometimes pathogenic
  11. 11. Continued…Runyon Group III (Slow growingnonchromogens)◦ M. avium complex – common◦ M. genavense◦ M. hemophilum uncommon◦ M. malmoenseStrictly pathogenicUsually pathogenic
  12. 12. Continued…Runyon Group IV (Rapid growers)◦ M. fortuitum◦ M. chelonae Common◦ M. abscessus◦ M. mucogenicum UncommonSometimes pathogenic
  14. 14. Structure and Physiology Weakly gram positive Strongly acid fast Aerobic bacilli
  15. 15. Mycobacterium TuberculosisStained with Fluorescent Dye
  16. 16. Lipid rich cell wall, makes organismresistant to◦ Disinfectants◦ Detergents◦ Common antibacterial antibiotic
  17. 17. Virulence Capable of intracellular growth inunactivated alveolar macrophages Disease primarily host response toinfection
  18. 18. Epidemiology Worldwide , one third of the populationis infected 16 million existing cases and 8 millionnew cases Most common in Southeast Asia,Sub- Shaharan Africa and EasternEurope
  19. 19. Continued…Patients at the greatest risk are the◦ Immunocompromised patients (HIV)◦ Drug and alcohol abusers◦ Homeless◦ Individuals exposed to infected patientsHumans are only the reservoirPerson to person infection by aerosols
  20. 20. Diseases Primary infection is lungs Dissemination to any other site occursmostly in the immunocompromisedand untreated persons
  21. 21. Diagnosis Positive PPD Chest X-Ray Microscopy and culture – it is sensitive
  22. 22. Treatment, Prevention andControl Multiple drugs regimens andprolonged treatment are required toprevent development of drugresistance strains MDR-TB is global health threat
  23. 23. Continued… Treatment include isoniazid andrifampin for 9 months + pyrazinamide+ ethambutol or streptomycin Immunoprophylaxis with BCG inendemic countries Control- active surveillance ,prophylactic and therapeuticinterventions and monitoring of thecase
  24. 24. Progression of Pulmonary TBPneumoniaGranuloma formation with fibrosisCaseous necrosis• Tissue becomes dry & amorphous (resemblingcheese)• Mixture of protein & fat (assimilated very slowly)Calcification• Ca++ salts depositedCavity formation• Center liquefies & empties into bronchi
  26. 26. Structure and Physiology Weakly gram positive Strongly acid fast bacilli Lipid rich cell wall Unable to culture on artificialmedium
  27. 27. Virulence Capable of intracellular growth Disease primarily from host responseto infection
  28. 28. Epidemiology Common in Africa and Asia Armadillos are naturally infected andare reservoir Lepromatous form of disease is highlyinfectious Spreads by inhalation of aerosols Individual in direct contact withpatients are at greater risk
  29. 29. Forms of Diseases Tuberculoid form of leprosy Lepromatous form of leprosy Intermediate form of leprosy
  30. 30. Diagnosis Microscopy is sensitive for thelepromatous but not for tuberculoidform Skin testing is required for tuberculoidleprosy Culture cannot be used
  31. 31. Treatment, Prevention andControl Dapsone with or without rifampin is usedto treat tuberculoid form Clofazimine is added for the lepromatousform Therapy is usually prolonged For prophylaxis –DAPSONE Control – by prompt recognition andtreatment of infected patients
  32. 32. Lepromatous form
  33. 33. Tuberculoid form
  34. 34. Pre and Post Treatment